Which of the following clump and adhere to the wall of the injured blood vessel to begin the process of hemostasis?

A. "The anticoagulant effect of a single dose of aspirin can last for as long as a month." This statement is incorrect. While aspirin has antiplatelet effects that inhibit blood clot formation, its duration of action is not as long as a month. Aspirin irreversibly inhibits the enzyme cyclooxygenase (COX), thereby inhibiting platelet aggregation. However, the effects on platelet function are not permanent, and platelets turnover within a few days, thus the anticoagulant effect of a single dose of aspirin typically lasts for a shorter duration.

B. "The anticoagulant effect of a single dose of aspirin can last for as long as a day." Aspirin's primary effect is on platelets, not directly on overall blood clotting. It inhibits the COX enzyme, reducing the production of thromboxane A2, a chemical that promotes platelet aggregation. The initial inhibition of platelet function is strongest within the first 24 hours after taking aspirin. However, the affected platelets remain dysfunctional for their entire lifespan (around 7-10 days).

C. "The anticoagulant effect of a single dose of aspirin can last for as long as a week." This statement is correct. Aspirin's effect on platelets is due to its irreversible inhibition of the COX enzyme. Platelets have a lifespan of about 7-10 days. Once a platelet is affected by aspirin, it cannot regain its function. As your body continuously produces new platelets, the overall antiplatelet effect gradually diminishes over time.

D. "The anticoagulant effect of a single dose of aspirin can last for as long as 12 hours."

Rationale: This statement is partially correct. The antiplatelet effect of aspirin does not typically last as short as 12 hours. While the peak inhibition of platelet function occurs within hours after administration, the duration of action is longer due to the irreversible inhibition of COX-1. However, stating that it lasts exactly 12 hours may not be entirely accurate for all individuals, as the duration of action can vary depending on factors such as individual metabolism and dose.

A. Have suction equipment at the bedside. Clopidogrel is an antiplatelet medication that inhibits blood clot formation. While it does not typically increase the risk of bleeding to the extent that requires constant suctioning, it's prudent to have suction equipment readily available for any patient who may be at risk of bleeding due to their underlying condition or concurrent medications. However, the administration of clopidogrel alone does not necessitate the need for constant suctioning.

B. Monitor the client for black, tarry stools. This is the correct answer. Clopidogrel, like other antiplatelet medications, increases the risk of bleeding, including gastrointestinal bleeding. Black, tarry stools can indicate gastrointestinal bleeding, which can be a serious complication of clopidogrel therapy. Therefore, monitoring for this symptom is essential for early detection of potential bleeding complications.

C. Administer the medication with each meal. Clopidogrel can be administered with or without food, as it is not significantly affected by food intake. However, there is no specific recommendation to administer it with meals. The timing of administration may vary based on the prescriber's instructions or patient preferences, but it does not need to be consistently administered with meals.

D. Initiate contact precautions. Clopidogrel therapy does not require contact precautions. Contact precautions are typically implemented for patients with contagious infections that spread via direct or indirect contact. Clopidogrel does not pose a risk of transmission to others and does not warrant contact precautions.